Discovery of drug targets for heart failure with preserved and reduced ejection fraction

Nat Cardiovasc Res. 2025 Mar;4(3):254-255. doi: 10.1038/s44161-024-00605-x.

Scott C Ritchie^{1

2

3

4

5

6}

¹ British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. sr827@medschl.cam.ac.uk.
² British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK. sr827@medschl.cam.ac.uk.
³ Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK. sr827@medschl.cam.ac.uk.
⁴ Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK. sr827@medschl.cam.ac.uk.
⁵ Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. sr827@medschl.cam.ac.uk.
⁶ Cambridge Baker Systems Genomics Initiative, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia. sr827@medschl.cam.ac.uk.

No abstract available